Renhe Pharmacy Co (SZSE:000650) Total Liabilities : ¥645 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Total Liabilities?

Renhe Pharmacy Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥645 Mil.

Renhe Pharmacy Co's quarterly Total Liabilities declined from Sep. 2024 (¥788.25 Mil) to Dec. 2024 (¥676.48 Mil) and declined from Dec. 2024 (¥676.48 Mil) to Mar. 2025 (¥644.67 Mil).

Renhe Pharmacy Co's annual Total Liabilities declined from Dec. 2022 (¥1,212.98 Mil) to Dec. 2023 (¥790.18 Mil) and declined from Dec. 2023 (¥790.18 Mil) to Dec. 2024 (¥676.48 Mil).

Renhe Pharmacy Co Total Liabilities Historical Data

The historical data trend for Renhe Pharmacy Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Total Liabilities Chart

Renhe Pharmacy Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

729.60

981.00

1,212.98

790.18

676.48

Renhe Pharmacy Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															920.84	1,008.75	788.25	676.48	644.67

Renhe Pharmacy Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Renhe Pharmacy Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	636.345	+	(1.888	+	38.063
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.182)
	=	676

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	7482.46	-	6805.983
	=	676

Renhe Pharmacy Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	605.877	+	(1.91	+	36.704
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.182)
	=	645

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	7651.458	-	7006.785
	=	645

Renhe Pharmacy Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Renhe Pharmacy Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038

Website

http://www.renheyaoye.com

Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.

Executives

Yang Xiao	Director
Kang Zhi Hua	Supervisors
Mei Qiang	Directors, executives
Yang Wen Long	Director

Renhe Pharmacy Co Headlines

No Headlines